Neuberger Comments on Prospects for Marijuana Breathalyzer Test
October 23, 2019
Business Insurance
Of Counsel Mark Neuberger was quoted in a Business Insurance article, “Marijuana drug test in works; could be relief for employers,” about the development of a new type of drug test for marijuana use that is set to hit the market next year.
Neuberger, co-chair of Foley’s Cannabis Industry Team, suggested that employers conduct field sobriety tests on employees suspected of marijuana impairment instead of just sending them out for drug testing. “There’s scientific evidence behind that” and it’s legally acceptable, he said. “You don’t need to be a law enforcement person to get training. If you suspect an employee in the workplace is impaired…put them through the test and make a reasonable determination.”
Neuberger, co-chair of Foley’s Cannabis Industry Team, suggested that employers conduct field sobriety tests on employees suspected of marijuana impairment instead of just sending them out for drug testing. “There’s scientific evidence behind that” and it’s legally acceptable, he said. “You don’t need to be a law enforcement person to get training. If you suspect an employee in the workplace is impaired…put them through the test and make a reasonable determination.”
People
Related News
March 13, 2026
In the News
Chris Babcock and Chris Converse on Wave of Companies Moving to Texas
Foley & Lardner LLP partners Chrisopher Babcock and Chris Converse commented on the widening trend of companies reincorporating to Texas in the Houston Business Journal article, “Texas law changes could spark wave of corporate redomestication proposals."
March 12, 2026
In the News
Louis Lehot Explores M&A's Growing Blitzhire Phenomenon
Foley & Lardner LLP partner Louis Lehot authors article on the emergence of blitzhires in the Mergers & Acquisitions article, “Blitzhires: The New Fast-Moving M&A Deal.”
March 10, 2026
In the News
Aaron Maguregui Shares Insights on Shadow AI Risks in Health Care
Foley & Lardner LLP partner Aaron Maguregui was quoted in the Part B News article, “Do you need AI policy? Experts suggest guardrails as 'shadow AI' spreads,” discussing the emerging risks of unsanctioned 'shadow AI' use by clinicians and the need to establish robust AI governance.